Coya Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of COYA?
Owner Type	Number of Shares	Ownership Percentage
Individual Insiders	1,306,110	5.57%
Public Companies	2,272,727	9.69%
Hedge Funds	2,335,540	9.96%
Institutions	5,822,489	24.8%
General Public	11,720,317	50%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 40.3%.

Top Shareholders

Top 25 shareholders own 47.28% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
9.96%	Greenlight Capital, Inc.	2,335,540	US$11.0m	0%	0.3%
9.69%	Dr. Reddy's Laboratories Limited	2,272,727	US$10.7m	0%	no data
4.16%	Aigh Capital Management, LLC	975,404	US$4.6m	0%	0.58%
4.05%	Howard Berman	949,338	US$4.5m	0%	no data
3.6%	Vanguard Capital Management, LLC	844,913	US$4.0m	0%	no data
3.41%	Alyeska Investment Group, L.P.	800,000	US$3.8m	0%	0.01%
1.79%	Prosight Management, LP	420,360	US$2.0m	0%	0.33%
1.6%	CM Management, LLC	375,000	US$1.8m	7.14%	1.27%
1.57%	Private Management Group Inc	369,096	US$1.7m	31.7%	0.05%
1%	Geode Capital Management, LLC	233,402	US$1.1m	17.9%	no data
0.96%	Marshall Wace LLP	225,792	US$1.1m	0.19%	no data
0.7%	Wilbur Ross	165,016	US$777.2k	0%	no data
0.6%	Vanguard Fiduciary Trust Company	139,886	US$658.9k	25%	no data
0.57%	Orin Hirschman	132,767	US$625.3k	0%	no data
0.44%	Renaissance Technologies LLC	103,964	US$489.7k	55.4%	no data
0.43%	Prelude Capital Management, LLC	101,330	US$477.3k	93.9%	0.03%
0.43%	JBF Capital, Inc.	100,006	US$471.0k	0%	0.06%
0.41%	Dimensional Fund Advisors LP	95,919	US$451.8k	205%	no data
0.36%	Morgan Stanley	84,700	US$398.9k	61.8%	no data
0.35%	BlackRock, Inc.	82,769	US$389.8k	4.58%	no data
0.34%	State Street Global Advisors, Inc.	79,813	US$375.9k	14.8%	no data
0.3%	683 Capital Management, LLC	70,000	US$329.7k	-12.6%	0.03%
0.2%	XTX Markets Limited	47,338	US$223.0k	43.1%	no data
0.19%	Edward Jones Trust Company	44,960	US$211.8k	786%	no data
0.17%	ADAR1 Capital Management, LLC	40,900	US$192.6k	0%	0.01%

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2026/05/27 16:59
End of Day Share Price	2026/05/27 00:00
Earnings	2026/03/31
Annual Earnings	2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Coya Therapeutics, Inc. is covered by 8 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Thomas Shrader	BTIG
Keay Nakae	Chardan Capital Markets, LLC
Jason Kolbert	D. Boral Capital LLC.